Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach
Joyce Oloaigbe Ogidigo, Emmanuel Amarachi Iwuchukwu, Collins U. Ibeji, Okiemute Ajiroghene Okpalefe, Mahmoud E. S. Soliman
Abstract
of SARS-CoV-2. However, urgent trials should be conducted to validate this outcome.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
ProteaseADMERibavirinHydroxychloroquinePharmacologyChemistryDrugCoronavirus disease 2019 (COVID-19)Traditional medicineEnzymeMedicineVirologyBiochemistryVirusInfectious disease (medical specialty)PathologyDiseaseHepatitis C virusTransgenic Plants and ApplicationsComputational Drug Discovery MethodsToxin Mechanisms and Immunotoxins